• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LIGHT/TNFSF14 缺陷小鼠的骨重塑损伤。

Impairment of Bone Remodeling in LIGHT/TNFSF14-Deficient Mice.

机构信息

Department of Basic and Medical Sciences, Neurosciences and Sense Organs, Section of Human Anatomy and Histology, University of Bari, Bari, Italy.

Department of Biomedical Science and Human Oncology, Paediatric Unit, University of Bari, Bari, Italy.

出版信息

J Bone Miner Res. 2018 Apr;33(4):704-719. doi: 10.1002/jbmr.3345. Epub 2017 Dec 11.

DOI:10.1002/jbmr.3345
PMID:29178458
Abstract

Multiple cytokines produced by immune cells induce remodeling and aid in maintaining bone homeostasis through differentiation of bone-forming osteoblasts and bone-resorbing osteoclasts. Here, we investigate bone remodeling controlled by the tumor necrosis factor (TNF) superfamily cytokine LIGHT. LIGHT-deficient mice (Tnfsf14 ) exhibit spine deformity and reduced femoral cancellous bone mass associated with an increase in the osteoclast number and a slight decrease of osteoblasts compared with WT mice. The effect of LIGHT in bone cells can be direct or indirect, mediated by both the low expression of the anti-osteoclastogenic osteoprotegerin (OPG) in B and T cells and reduced levels of the pro-osteoblastogenic Wnt10b in CD8 T cells in Tnfsf14 mice. LIGHT stimulation increases OPG levels in B, CD8 T, and osteoblastic cells, as well as Wnt10b expression in CD8 T cells. The high bone mass in Light and T- and B-cell-deficient mice (Rag /Tnfsf14 ) supports the cooperative role of the immune system in bone homeostasis. These results implicate LIGHT as a potential target in bone disease. © 2017 American Society for Bone and Mineral Research.

摘要

多种免疫细胞产生的细胞因子通过成骨细胞(osteoblasts)和破骨细胞(osteoclasts)的分化诱导重塑,并有助于维持骨内稳态。在这里,我们研究了肿瘤坏死因子(TNF)超家族细胞因子 LIGHT 控制的骨重塑。与 WT 小鼠相比,LIGHT 缺陷型小鼠(Tnfsf14)表现出脊柱畸形和股骨松质骨量减少,其与破骨细胞数量增加和成骨细胞数量略有减少有关。LIGHT 在骨细胞中的作用可以是直接的,也可以是间接的,既可以通过 B 和 T 细胞中抗破骨细胞生成的骨保护素(osteoprotegerin,OPG)表达降低以及 CD8 T 细胞中促成骨细胞生成的 Wnt10b 水平降低来介导,也可以通过这种方式来介导。LIGHT 刺激可增加 B、CD8 T 和成骨细胞中的 OPG 水平,以及 CD8 T 细胞中的 Wnt10b 表达。Light 和 T、B 细胞缺陷型小鼠(Rag /Tnfsf14)中的高骨量支持免疫系统在骨内稳态中的协同作用。这些结果表明 LIGHT 可能是骨疾病的一个潜在靶点。

相似文献

1
Impairment of Bone Remodeling in LIGHT/TNFSF14-Deficient Mice.LIGHT/TNFSF14 缺陷小鼠的骨重塑损伤。
J Bone Miner Res. 2018 Apr;33(4):704-719. doi: 10.1002/jbmr.3345. Epub 2017 Dec 11.
2
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss.LIGHT/TNFSF14 调节雌激素缺乏引起的骨丢失。
J Pathol. 2020 Apr;250(4):440-451. doi: 10.1002/path.5385. Epub 2020 Feb 25.
3
Skeletal inflammation and attenuation of Wnt signaling, Wnt ligand expression, and bone formation in atherosclerotic ApoE-null mice.动脉粥样硬化ApoE基因敲除小鼠的骨骼炎症以及Wnt信号传导、Wnt配体表达和骨形成的减弱。
Am J Physiol Endocrinol Metab. 2016 May 1;310(9):E762-73. doi: 10.1152/ajpendo.00501.2015. Epub 2016 Mar 8.
4
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.成骨细胞产生的骨保护素是破骨细胞发育和功能的重要调节因子。
Endocrinology. 2000 Sep;141(9):3478-84. doi: 10.1210/endo.141.9.7634.
5
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.衰老会增加基质/成骨细胞诱导的破骨细胞生成,并改变小鼠体内破骨细胞前体细胞库。
J Bone Miner Res. 2005 Sep;20(9):1659-68. doi: 10.1359/JBMR.050503. Epub 2005 May 2.
6
Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation.前列腺素E2对骨保护素表达的抑制在脂多糖诱导的破骨细胞形成中起关键作用。
J Immunol. 2004 Feb 15;172(4):2504-10. doi: 10.4049/jimmunol.172.4.2504.
7
Contradictory Role of CD97 in Basal and Tumor Necrosis Factor-Induced Osteoclastogenesis In Vivo.CD97 在体内基础和肿瘤坏死因子诱导的破骨细胞生成中的矛盾作用。
Arthritis Rheumatol. 2016 May;68(5):1301-13. doi: 10.1002/art.39538.
8
Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation.Wnt10b通过增强成骨细胞分化来增加出生后骨形成。
J Bone Miner Res. 2007 Dec;22(12):1924-32. doi: 10.1359/jbmr.070810.
9
Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption.骨保护素缺乏可减弱锶对破骨细胞生成和骨吸收的抑制作用。
J Bone Miner Res. 2011 Jun;26(6):1272-82. doi: 10.1002/jbmr.325.
10
Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells.LIGHT/LTβR/HVEM通路的免疫治疗靶向作用完全重现了LIGHT缺陷型T细胞降低的细胞毒性表型。
MAbs. 2016;8(3):478-90. doi: 10.1080/19420862.2015.1132130. Epub 2016 Jan 11.

引用本文的文献

1
LIGHT/TNFSF14 Affects Adipose Tissue Phenotype.LIGHT/TNFSF14 影响脂肪组织表型。
Int J Mol Sci. 2024 Jan 5;25(2):716. doi: 10.3390/ijms25020716.
2
High levels of LIGHT/TNFSF14 in patients with Prader-Willi syndrome.普拉德-威利综合征患者体内高水平的 LIGHT/TNFSF14。
J Endocrinol Invest. 2023 Sep;46(9):1901-1909. doi: 10.1007/s40618-023-02050-2. Epub 2023 Mar 14.
3
Editorial: Special Issue on "Molecular Mechanisms Regulating Osteoclastogenesis".社论:“调节破骨细胞生成的分子机制”专刊
Int J Mol Sci. 2020 Oct 15;21(20):7643. doi: 10.3390/ijms21207643.
4
Shedding "LIGHT" on the Link between Bone and Fat in Obese Children and Adolescents.揭示肥胖儿童和青少年骨与脂肪之间关联的“LIGHT”。
Int J Mol Sci. 2020 Jul 3;21(13):4739. doi: 10.3390/ijms21134739.
5
MicroRNA-29a Counteracts Glucocorticoid Induction of Bone Loss through Repressing TNFSF13b Modulation of Osteoclastogenesis.MicroRNA-29a 通过抑制 TNFSF13b 对破骨细胞生成的调节作用来拮抗糖皮质激素诱导的骨丢失。
Int J Mol Sci. 2019 Oct 17;20(20):5141. doi: 10.3390/ijms20205141.
6
Mechanisms Involved in Childhood Obesity-Related Bone Fragility.儿童肥胖相关骨脆性的发病机制。
Front Endocrinol (Lausanne). 2019 May 3;10:269. doi: 10.3389/fendo.2019.00269. eCollection 2019.
7
Updates on Osteoimmunology: What's New on the Cross-Talk Between Bone and Immune System.骨免疫学的最新进展:骨骼与免疫系统相互作用的新动态
Front Endocrinol (Lausanne). 2019 Apr 18;10:236. doi: 10.3389/fendo.2019.00236. eCollection 2019.
8
LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens.LIGHT/TNFSF14 作为多发性骨髓瘤患者接受治疗方案时骨病的新生物标志物。
Front Immunol. 2018 Oct 23;9:2459. doi: 10.3389/fimmu.2018.02459. eCollection 2018.
9
An update on the role of RANKL-RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases.关于 RANKL-RANK/osteoprotegerin 和 WNT-ß-catenin 信号通路在儿科疾病中的作用的最新研究进展。
World J Pediatr. 2019 Feb;15(1):4-11. doi: 10.1007/s12519-018-0198-7. Epub 2018 Oct 20.